Orris

Bilirubin of 14 in physiological jaundice in a 5 day old

Reading File
Finding Sources
Finding Sources
Searching the Web

physiological jaundice neonate bilirubin 14 management phototherapy threshold 2025

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Here is a comprehensive answer:

Bilirubin of 14 mg/dL in Physiological Jaundice — Day 5 Neonate

Is this within the physiological range?

Yes, 14 mg/dL on day 5 can still fall within the upper limits of physiological jaundice, but it requires careful risk stratification rather than routine dismissal.
Key physiological jaundice benchmarks:
  • Appears days 2–3 of life (never day 1)
  • Peaks around day 4–5 (term infants), typically at 6 mg/dL in healthy infants
  • Rarely rises >5 mg/dL/day
  • Classically <20 mg/dL (levels above this exceed albumin-binding capacity)
  • Declines to normal by ~2 weeks
A bilirubin of 14 mg/dL on day 5 is elevated above the average physiological peak and sits in a range where phototherapy decisions depend on gestational age and neurotoxicity risk factors.
— Rosen's Emergency Medicine, p. 3226

Phototherapy Decision (AAP Guidelines)

For a ≥35-week gestation infant at ~120 hours (5 days) of age:
Risk CategoryPhototherapy Threshold (~120 hrs)
Low risk (≥38 wk, no risk factors)~18–20 mg/dL
Medium risk (≥38 wk + risk factors, or 35–37 wk)~15–17 mg/dL
Higher risk (35–37 wk + risk factors)~13–15 mg/dL
At 14 mg/dL on day 5, a low-risk term infant would not yet meet the phototherapy threshold. However, a near-term (35–37 wk) or higher-risk infant would warrant phototherapy at this level.
Risk factors that lower the threshold:
  • Isoimmune hemolytic disease (ABO/Rh incompatibility)
  • G6PD deficiency
  • Asphyxia, sepsis, acidosis
  • Prematurity (35–37 weeks)
  • Significant lethargy, temperature instability
— Rosen's Emergency Medicine, p. 3228 (AAP Fig. 166.1A)

Pathological Features to Exclude

Before labeling as physiological, rule out:
  • Jaundice within first 24 hours → always pathological
  • Rise >5 mg/dL/day → suggests hemolysis
  • Conjugated (direct) bilirubin >1 mg/dL or >20% of total → always pathological
  • Persistent beyond 3 weeks → investigate
Pathological causes (unconjugated): ABO/Rh incompatibility, G6PD deficiency, hereditary spherocytosis, sepsis, TORCH infections, Crigler-Najjar syndrome, Gilbert syndrome, cephalohematoma.

Danger Level: Kernicterus

Unconjugated bilirubin becomes neurotoxic when it exceeds albumin-binding capacity (~20–25 mg/dL). At 14 mg/dL, the infant is not in the danger zone, but the trajectory matters.
Bilirubin-induced neurologic dysfunction (BIND) features:
  • Early: poor feeding, lethargy, high-pitched cry
  • Progressive: hypertonia, retrocollis, opisthotonos
  • Late/irreversible: cerebral palsy, sensorineural hearing loss, upward gaze palsy
— Harper's Illustrated Biochemistry; Rosen's Emergency Medicine, p. 3227

Management at 14 mg/dL, Day 5

  1. Assess risk category (gestational age + risk factors above)
  2. Check total + direct bilirubin to confirm unconjugated predominance
  3. If phototherapy threshold is met → intensive phototherapy (continuous broad-spectrum blue light, ~460–490 nm)
  4. Ensure adequate hydration and feeding (breastfeeding support; supplemental feeding if poor intake/weight loss >10%)
  5. Repeat TSB 4–6 hours after starting phototherapy to confirm response
  6. Exchange transfusion only if bilirubin approaches age-specific exchange threshold (generally ~20–25 mg/dL at this age, depending on risk) or BIND signs appear
  7. Home phototherapy is an option for well-appearing, low-risk infants with reliable caregivers and 24-hour follow-up access
Stop phototherapy when TSB falls ~3 mg/dL below the treatment threshold.
This is a shared conversation. Sign in to Orris to start your own chat.